Kathleen Kirby

Company: Merlin Therapeutics

Job title: Chief Operating Officer

Seminars:

Panel Discussion: Addressing Challenges Associated with Viral Delivery Approaches 2:00 pm

• Selecting the right delivery system to reduce unintended gene edits and increase accuracy • Analyzing the benefits and drawbacks of using viral vectors for gene delivery • Strategies for decreasing immune responses and enhancing the overall safety profile of gene-editing technologiesRead more

day: Day 2- translation 2

Panel Discussion: Breaking Boundaries: Navigating the Shift from Rare to Common Diseases in Gene Therapy 1:30 pm

• Exploring the unique challenges and benefits of expanding gene therapy into more prevalent conditions, including patient access, cost, and treatment scalability • Evaluating the feasibility of widespread gene therapy applications in common diseases by 2025, along with realistic goals and potential hurdles • Essential factors for successful translation, including regulatory preparedness, CMC adaptation, and…Read more

day: Focus Day

Roundtable: Overcoming the Challenges and & Maximizing Opportunities for Gene Therapy in Common Diseases 10:00 am

• Tackling the technical, regulatory, and financial barriers to gene therapy adoption in widespread conditions • Strategies to optimize manufacturing processes and reduce costs while maintaining efficacy and quality for larger populations • Identifying market access opportunities and pathways to ensure successful commercialization and patient accessRead more

day: Focus Day